Wedbush Raises CNC PT To $37

Wedbush has raised the Price Target on Centene CNC from $31 to $37 a share. Wedbush writes, “Our Increased Estimates Reflect our Belief that Utilization and Flu Trends Remain Moderate. We also have confidence in the company's claims clarity and rapid response to outliers and see further upside potential from robust medical management and updated enrollment numbers from March in several markets.” CNC is rated Outperform and traded at $32.11 yesterday at closing.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareManaged Health CareWebush
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!